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Summary 
Background Diagnosis of gestational diabetes predicts risk of infants who are large for gestational age (LGA) and with 
high adiposity, which in turn aims to predict a future risk of obesity in the oﬀ spring. South Asian women have higher 
risk of gestational diabetes, lower risk of LGA, and on average give birth to infants with greater adiposity than do white 
European women. Whether the same diagnostic criteria for gestational diabetes should apply to both groups of women 
is unclear. We aimed to assess the association between maternal glucose and adverse perinatal outcomes to ascertain 
whether thresholds used to diagnose gestational diabetes should diﬀ er between south Asian and white British women. 
We also aimed to assess whether ethnic origin aﬀ ected prevalence of gestational diabetes irrespective of criteria used.
Methods We used data (including results of a 26–28 week gestation oral glucose tolerance test) of women from the 
Born in Bradford study, a prospective study that recruited women attending the antenatal clinic at the Bradford Royal 
Inﬁ rmary, UK, between 2007 and 2011 and who intended to give birth to their infant in that hospital. We studied the 
association between fasting and 2 h post-load glucose and three primary outcomes (LGA [deﬁ ned as birthweight 
>90th percentile for gestational age], high infant adiposity [sum of skinfolds >90th percentile for gestational age], and 
caesarean section). We calculated adjusted odds ratios (ORs) and their 95% conﬁ dence intervals (CIs) for a 1 SD 
increase in fasting and post-load glucose. We established fasting and post-load glucose thresholds that equated to an 
OR of 1·75 for LGA and high infant adiposity in each group of women to identify ethnic-speciﬁ c criteria for diagnosis 
of gestational diabetes.
Findings Of 13 773 pregnancies, 3420 were excluded from analyses. Of 10 353 eligible pregnancies, 4088 women were 
white British, 5408 were south Asian, and 857 were of other ethnic origin. The adjusted ORs of LGA per 1 SD fasting 
glucose were 1·22 (95% CI 1·08–1·38) in white British women and 1·43 (1·23–1·67) in south Asian women 
(pinteraction with ethnicity =0·39). Results for high infant adiposity were 1·35 (1·23–1·49) and 1·35 (1·18–1·54; pinteraction with ethnicity =0·98), 
and for caesarean section they were 1·06 (0·97–1·16) and 1·11 (1·02–1·20; pinteraction with ethnicity =0·47). Associations between 
post-load glucose and the three primary outcomes were weaker than for fasting glucose. A fasting glucose concentration 
of 5·4 mmol/L or a 2 h post-load level of 7·5 mmol/L identiﬁ ed white British women with 75% or higher relative risk 
of LGA or high infant adiposity; in south Asian women, the cutoﬀ s were 5·2 mmol/L or 7·2 mml/L; in the whole 
cohort, the cutoﬀ s were 5·3 mmol/L or 7·5 mml/L. The prevalence of gestational diabetes in our cohort ranged from 
1·2% to 8·7% in white British women and 4% to 24% in south Asian women using six diﬀ erent criteria. Compared 
with the application of our whole-cohort criteria, use of our ethnic-speciﬁ c criteria increased the prevalence of 
gestational diabetes in south Asian women from 17·4% (95% CI 16·4–18·4) to 24·2% (23·1–25·3).
Interpretation Our data support the use of lower fasting and post-load glucose thresholds to diagnose gestational 
diabetes in south Asian than white British women. They also suggest that diagnostic criteria for gestational diabetes 
recommended by UK NICE might underestimate the prevalence of gestational diabetes compared with our criteria or 
those recommended by the International Association of Diabetes and Pregnancy Study Groups and WHO, especially 
in south Asian women.
Funding The National Institute for Health Research.
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Introduction
Gestational diabetes increases the risk of several adverse 
perinatal outcomes.1 In recent years, there has been 
much debate about how gestational diabetes should be 
diagnosed. In 2010, the International Association of 
Diabetes and Pregnancy Study Groups (IADPSG) 
recommended new thresholds for the diagnosis of the 
disease, which aimed to reduce obesity risk by 
identifying infants who were large for gestational age 
(LGA), with high adiposity at birth, and who had high 
concentrations of cord-blood C-peptide.2 In 2013, WHO, 
whose previous criteria for diagnosing gestational 
diabetes have been widely used, endorsed the IADPSG 
criteria.3
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The IADPSG criteria were produced with results from 
the Hyperglycemia and Adverse Pregnancy Outcomes 
(HAPO) study,4 which aimed to establish the association 
between maternal glucose concentrations that did not 
meet criteria for overt diabetes (pre-existing diabetes or 
gestational diabetes) and risk of adverse perinatal 
outcomes. HAPO found graded linear associations of 
fasting and post-load maternal glucose with LGA, high 
adiposity, and high concentrations of cord-blood 
C-peptide, and similar linear associations with several 
other perinatal outcomes. In view of the absence of any 
clear threshold of glucose concentration at which risk of 
adverse outcomes increased, the IADPSG reached a 
consensus on how to calculate the new criteria. They 
decided that the thresholds for diagnosing gestational 
diabetes would be: the glucose values at which the odds 
ratios (ORs) reached 1·75 for birthweight greater than 
the 90th percentile, percent infant body fat (based on 
skinfolds) greater than the 90th percentile, and 
concentration of cord C-peptide greater than the 
90th percentile.2 Although in most populations the 
application of the IADPSG criteria increases the 
number of women diagnosed with gestational diabetes 
compared with most previously used criteria (table 1),8 
they might not identify women at risk who have a high 
2 h post-load glucose but still below that speciﬁ ed by the 
IADPSG criteria.4 
It is unclear whether the association between maternal 
glucose and perinatal outcomes and the IADPSG criteria 
for diagnosing gestational diabetes should be the same in 
south Asian women, who are at higher risk of gestational 
diabetes than white European women.9 The shift in the 
aim of diagnosing gestational diabetes from one of 
identifying women at risk of type 2 diabetes to one of 
identifying risk of future oﬀ spring obesity is especially 
important for south Asians, because south Asian women, 
Research in context
Evidence before this study
We searched MEDLINE and MEDLINE in Process, Embase, 
CINAHL Plus, Cochrane Central Register of Controlled Trials 
(CENTRAL), Cochrane Database of Systematic Reviews (CDSR), 
Database of Abstracts of Reviews of Eﬀ ectiveness (DARE), 
Health Technology Assessment database (HTA), NHS Economic 
Evaluation Database (NHS EED), and the Cochrane 
Methodology Register for various combinations of the terms 
including: “gestational diabetes” or “diabetes” and “pregnancy” 
and “birth injury” or “macrosomia” or “large for gestational 
age” or “labour complications” or “shoulder dystocia” or 
“fracture” (“clavicle”, “humerus”, “shoulder”, “arm”) or “Erb’s 
palsy”or “pre-eclampsia” or “eclampsia” or “cardiovascular 
disease” or “obesity” or “hypoglycaemia” or “neonatal unit 
admission” or “special care unit admission”. In initially 
screening papers for eligibility, we focused exclusively on those 
with titles in English (noting that the databases we search 
provide English titles for most papers irrespective of the 
language in which the main paper is written). We included 
papers in any language so long as we were able to obtain a 
translation. We undertook three searches between March, 
2013, and October, 2014, using the same databases and terms, 
and identiﬁ ed 28 eligible studies (all in English language) 
investigating the association between gestational glucose 
concentrations and adverse perinatal outcomes. The appendix 
shows the full list of references. Most studies were 
observational, included a general obstetric population, and 
were undertaken in several countries. Studies used diﬀ erent 
methods, glucose tolerance testing strategies, and assessed 
diﬀ erent outcomes. Generally, existing studies showed 
monotonic associations of maternal glucose concentrations 
with adverse perinatal outcomes (speciﬁ cally large for 
gestational age [LGA], macrosomia, and caesarean section) and 
no evidence of a threshold eﬀ ect. There was no strong evidence 
for an increase in odds of preterm delivery with greater 
maternal glucose. We did not identify any previous study that 
compared associations of glucose with perinatal outcomes 
between south Asian and white European women.
Added value of this study
We hypothesised that the association between gestational 
diabetes and perinatal outcomes, and the criteria for 
diagnosing gestational diabetes, might diﬀ er in south Asian 
compared with white British women. Our ﬁ ndings show that, 
as in white British women, women of south Asian origin have 
graded linear associations of fasting and 2 h post-load glucose 
with adverse perinatal outcomes including LGA and higher 
birth adiposity (as deﬁ ned by skinfold thicknesses >90th 
percentile). Our data suggest lower thresholds for diagnosing 
gestational diabetes in south Asian women than white 
European women.
Implications of all the available evidence
In view of the linear association of pregnancy glucose 
concentrations with adverse perinatal outcomes in south Asian, 
as in white European women, reducing the thresholds used to 
diagnose gestational diabetes will identify more women at risk 
of adverse perinatal outcomes. Eﬀ ective, safe, and cheap 
treatments are available for gestational diabetes that reduce 
glucose concentrations across its range and improve perinatal 
outcomes. Therefore, use of the criteria we developed in this 
study, or the International Association of Diabetes and 
Pregnancy Study Groups (IADPSG)/WHO criteria for diagnosing 
gestational diabetes in white European women, and our 
ethnic-speciﬁ c criteria for south Asian women, might improve 
perinatal outcomes. However, any eﬀ ect of lowering the 
thresholds to diagnose gestational diabetes on long-term 
oﬀ spring health requires assessment in large studies with data 
from maternal oral glucose tolerance tests and long-term 
detailed assessment of oﬀ spring. 
See Online for appendix
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on average, have infants of markedly lower birthweight 
and a reduced risk of LGA than white European women.7,8 
However, lower birthweight of south Asian infants masks 
a propensity to greater adiposity and associated 
cardiometabolic risk in later life.10–16 High maternal 
pregnancy glucose is an important mediator of greater 
birth adiposity in south Asian compared with white 
European infants.6 Although ﬁ ndings of the HAPO study 
showed similar associations across diﬀ erent geographical 
centres, there were no south Asian centres, and too few 
south Asian participants to assess the association between 
maternal glycaemia and perinatal outcomes.
We aimed to establish whether the IADPSG criteria for 
diagnosis of gestational diabetes are appropriate for 
south Asian women and to assess how the prevalence of 
gestational diabetes varies when diﬀ erent criteria for its 
diagnosis are used in south Asian and white British 
women. Our speciﬁ c objectives were to establish the 
nature of the association of fasting and post-load glucose 
with adverse perinatal outcomes in a large cohort of 
south Asian women and compare those ﬁ ndings with a 
similarly sized cohort of white British women; to use our 
results to identify appropriate thresholds for diagnosing 
gestational diabetes in south Asian and white British 
women; and to compare the prevalence of gestational 
diabetes in these two groups with diﬀ erent criteria. We 
hypothesised that the association between fasting and 
post-load glucose and birthweight and infant adiposity, 
and the thresholds used to diagnose gestational diabetes, 
would diﬀ er between south Asian and white British 
women. Furthermore, we predicted that prevalence of 
gestational diabetes would be greater in south Asian 
women than white British women irrespective of criteria 
used. Our ﬁ ndings should inform clinical practice for 
diagnosing gestational diabetes.
Methods
Study design and participants
Born in Bradford17 is a prospective birth cohort study of 
women who delivered a live singleton baby at the Bradford 
Royal Inﬁ rmary, Bradford, UK. Figure 1 shows full 
inclusion and exclusion of women from Born in Bradford 
in this study. Women were excluded from all analyses if 
they did not complete a baseline questionnaire or the oral 
glucose tolerance test or had missing data for ethnic 
origin. For the main analyses of the association of 
gestational glucose with perinatal outcomes and 
development of gestational diabetes diagnostic criteria, we 
excluded women diagnosed with gestational diabetes. 
Gestational diabetes was deﬁ ned according to modiﬁ ed 
WHO criteria operating at the time (either fasting glucose 
≥6·1 mmol/L, or 2 h post-load glucose ≥7·8 mmol/L).5,6
The cohort is broadly representative of the obstetric 
population in Bradford.17 All women booked for delivery in 
Bradford are oﬀ ered a 75 g oral glucose tolerance test 
(comprising fasting and 2 h post-load samples) at around 
26–28 weeks’ gestation, and women were recruited mainly 
at their oral glucose tolerance test appointment. At 
recruitment, women had their height and weight 
measured, completed an interviewer-administered 
questionnaire, and provided written consent for 
information to be abstracted from their medical records. 
Interviews were done in English or in south Asian 
languages (including Urdu and Mirpuri). Analysis of 
glucose samples was done using a Siemens Advia 2400 
analyser following a standard protocol. The coeﬃ  cients of 
variation range between 1·73% at 3·2 mmol/L and 0·64% 
at 19·1 mmol/L. Ethics approval was obtained from the 
Bradford Research Ethics Committee (07/H1302/112). All 
participants provided informed written consent.
Outcomes
We assessed associations of maternal glucose con-
centrations with three primary outcomes: LGA (deﬁ ned 
as birthweight greater than the 90th percentile for 
gestational age), infant adiposity (deﬁ ned as sum of 
skinfolds greater than the 90th percentile for gestational 
age), and caesarean section; and ﬁ ve secondary outcomes: 
pre-eclampsia, preterm delivery, shoulder dystocia, 
instrumental vaginal delivery, and admission to the 
neonatal unit. These outcomes are established clinical 
complications of gestational diabetes, and similar to the 
primary and secondary outcomes in the HAPO study. We 
did not have information about cord-blood C-peptide or 
neonatal hypoglycaemia in our cohort. We were unable 
to calculate percentage body fat from skinfolds as done in 
HAPO because no equivalent formulae exist for south 
Asian infants; thus, we used a cutoﬀ  of greater than the 
90th percentile for the sum of skinfolds. We included 
caesarean section in our analyses because although it is 
not used to predict future risk of adiposity and ill health, 
it is an important perinatal outcome and is associated 
with LGA, greater infant adiposity, and increased health 
service costs.18 
Birthweight, mode of delivery (normal vaginal, 
instrumented vaginal, or caesarean section), gestational 
age, pre-eclampsia, shoulder dystocia, and admission to 
the neonatal unit were obtained from hospital records. 
Glucose thresholds (mmol/L)* Years used Coverage of use
Fasting 1 h 
post-load
2 h 
post-load
HAPO exclusion5 5·8 .. 11·1 2002 Some US cities
WHO (previous)5 7·0 .. 7·8 1999–2013 Widespread 
worldwide
WHO (previous, modiﬁ ed)6 6·1 .. 7·8 1999 to present UK
UK NICE7 5·6 .. 7·8 2015 UK
IADPSG and WHO (present)2, 3 5·1 10·8 8·5 2010/13 to present Widespread 
worldwide
HAPO=Hyperglycaemia and Adverse Pregnancy Outcomes study. NICE=National Institute for health and Care 
Excellence. IADPSG=International Association of Diabetes and Pregnancy Study Groups.*All values are for a glucose 
tolerance test undertaken at about 26–28 weeks of gestation. 
Table 1: Diﬀ erent criteria used for diagnosis of gestational diabetes 
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Caesarean section was compared with all vaginal 
deliveries. Pre-eclampsia was deﬁ ned as new-onset 
proteinuria (>300 g in 24 h) together with blood pressure 
of 140/90 mm Hg or higher after 20 weeks’ gestation on 
more than one occasion. Birthweights were converted 
into standard deviation scores standardised for 
gestational age and sex relative to the UK-WHO growth 
standard.19,20 Infants were then categorised as either 
being greater than the 90th percentile or not.11 The UK-
WHO growth standards are based on data from six 
counties (USA, Norway, Oman, Brazil, India, and 
Ghana) and describe the optimum pattern of growth for 
all children, rather than the prevailing pattern in the 
UK.20 Skinfold thickness (triceps and subscapular) were 
summed and the 90th percentile was established from 
quantile regression using six sex–ethnic groups 
(combining sex, and ethnic origin [white British, south 
Asian, and other]) and adjusted for parity (0, 1, 2, 3+).21 
The intra-rate and inter-rate technical error of 
measurements for the skinfold thicknesses were, 
respectively, 0·22 to 0·35 mm and 0·15 to 0·54 mm for 
triceps, and 0·14 to 0·25 mm and 0·17 to 0·63 mm for 
subscapular skinfolds.22
Statistical analysis
Associations of fasting and post-load glucose with 
outcomes were assessed by categories, and with glucose 
as a continuous variable (per SD). We used multivariable 
logistic regression with clustered sandwich estimators23 
(to account for some women in the cohort having more 
than one pregnancy) to assess associations of fasting and 
post-load glucose with each outcome. We followed the 
analytical protocol used in the HAPO study as closely as 
possible, with fasting and post-load glucose 
concentrations divided into seven categories (see table 2 
footnotes for deﬁ nition of categories). In order to explore 
any extreme threshold eﬀ ects, the top two categories for 
fasting and post-load glucose included about 1% and 3% 
of women, respectively.
Models were adjusted for gestational age at oral glucose 
tolerance test, presence or absence of family history of 
diabetes, family history of hypertension, previous 
gestational diabetes, previous macrosomia, smoking 
status, alcohol consumption during pregnancy, maternal 
age and BMI, maternal education, baby sex, and parity. 
Models for all women were additionally adjusted for ethnic 
origin. Models for south Asian women were not adjusted 
for alcohol consumption during pregnancy because most 
reported never drinking alcohol. Additionally, preterm 
delivery was adjusted for squared maternal BMI because 
of evidence of a quadratic relationship of BMI with preterm 
delivery. Shoulder dystocia models were not adjusted for 
previous gestational diabetes due to small numbers. The 
appendix provides full details of the categorisation of these 
variables.
We established fasting and post-load glucose thresholds 
for birthweight greater than the 90th percentile and 
standardised sum of skinfolds greater than the 
90th percentile that equated to an odds ratio (OR) of 1·75, 
using the methods of the IADPSG2 (appendix).
All analyses were undertaken separately in white 
British and south Asian women and we tested for 
diﬀ erences in associations by including an interaction 
term between glucose and ethnic origin. Because women 
of south Asian origin were mainly Pakistani, we 
undertook a sensitivity analysis in which we repeated 
analyses only including Pakistani women.
To maximise statistical power and minimise bias that 
might occur if women with missing data were excluded 
from analyses, we used multivariate multiple imputation 
with chained equations to impute missing values24 
(appendix). We repeated all analyses with the complete 
data cohort for comparison. The appendix gives additional 
details of the statistical analyses.
Figure 1: Study sample
The criteria used in the hospital in which study participants were recruited to 
diagnose gestational diabetes (and hence exclude them from the analyses 
presented here) were either fasting glucose ≥6·1 mmol/L or 2 h post-load 
glucose ≥7·8 mmol/L.
13 773 total number of
pregnancies
(12 450 women) 
712 women excluded
412 did not deliver at 
Bradford Royal Infirmary
162 multiple pregnancy
71 stillbirth
67 existing diabetes 
13 061 potentially eligible cohort 
10 353 available analysis cohort
4088 white British
5408 south Asian
857 other  
9496 comparing gestational 
diabetes prevalence analyses
4088 white British
5408 south Asian  
9509 main analysis (comparison 
of relationship of gestational
glucose to perinatal outcomes,
estimating diagnostic criteria)
3888 white British
4821 south Asian
800 other
2708 women had missing data
2243 did not complete 
baseline questionnaire
444 did not complete
oral glucose tolerance 
test
21 missing data on
ethnicity 
800 other ethnicity excluded 844 gestational diabetes excluded
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Role of the funding source
The funding bodies had no role in study design, data 
collection or analysis, decision to publish, or preparation 
of the manuscript. The corresponding author had access 
to all data and made the ﬁ nal decision to submit for 
publication. 
Results
Women were recruited to the Born in Bradford study 
between March, 2007, and November, 2010; investigators 
collected detailed information about 12 450 women 
(13  773 pregnancies resulting in 13 818 births). After 
exclusions, 9509 women (4821 south Asian and 
3888 white British) were included in the main analyses 
looking at associations of fasting and post-load glucose 
with adverse perinatal outcomes. 844 women with 
gestational diabetes excluded from main analyses were 
included in the analyses that compared the prevalence of 
gestational diabetes with diﬀ erent criteria. The appendix 
shows characteristics of the women and infants in the 
eligible cohort: 51% were south Asian, 41% were white 
British, and 8% were of other ethnic origin. Median 
fasting and post-load glucose concentrations were 
slightly higher in south Asian than white British women. 
White British infants were almost three times more 
likely than south Asian infants to have a birthweight 
greater than the 90th percentile, but the frequency of 
sum of skinfolds greater than the 90th percentile was 
similar in white British and south Asian infants. 
Characteristics were similar in the larger cohort of 
eligible women as in those included in the main analysis 
cohort (appendix).
Figure 2 shows the unadjusted percentage of women in 
each group that had each of the three primary outcomes 
by categories of fasting and 2 h post-load glucose. 
Generally, the frequency of each of the three primary 
outcomes increased across the seven categories of fasting 
and post-load glucose, with no evidence of a threshold at 
which risk markedly increases, except for the association 
of fasting glucose with caesarean section in south Asian 
women. The higher prevalence of birthweight greater 
than the 90th percentile in white British infants, 
compared with south Asian, is consistent across all 
glucose categories. Combining data for all women (ie, 
including 99% of the cohort) showed monotonic 
relationships of fasting and post-load glucose up to the 
6th category (appendix). 
Regression analyses conﬁ rmed monotonic associations 
of glucose with each of the primary outcomes, in each 
group, without (appendix) and with adjustment for 
confounders (table 2). In view of the monotonic nature of 
the associations, we focused our comparisons on results 
with fasting or post-load glucose as a continuous variable 
(per 1 SD). Although there was not strong statistical 
evidence of diﬀ erences, the point estimates suggested 
stronger associations of fasting and post-load glucose 
with all three outcomes except for those of fasting 
glucose with LGA and post-load glucose with Caesarean 
section. However, there was no strong statistical evidence 
that the associations diﬀ ered between the two groups for 
any primary outcome (pinteraction ≥0·2 for all associations).
Associations with secondary outcomes were similar in 
the two ethnic groups (appendix). The frequency of pre-
eclampsia, shoulder dystocia and, with a weaker 
magnitude, instrumental delivery, also increased across 
each glucose category, especially with fasting glucose 
(appendix). Neither fasting nor post-load glucose 
concentrations were clearly associated with preterm 
delivery or admission to the neonatal unit.
All women (N=9509) 
OR (95% CI)
White British 
(N=3888) 
OR (95% CI)
South Asian 
(N=4821) 
OR (95% CI)*
pinteraction*
Outcome by fasting glucose category† and per 1 SD
Birthweight >90th percentile
1 (Reference) 1·00 1·00 1·00 0·39
2 1·18 (0·90–1·54) 1·15 (0·83–1·59) 1·07 (0·59–1·94) ..
3 1·35 (1·04–1·74) 1·38 (1·01–1·90) 1·10 (0·65–1·88) ..
4 1·42 (1·02–1·97) 1·57 (1·04–2·37) 1·05 (0·56–1·98) ..
5 1·90 (1·35–2·67) 1·59 (0·97–2·62) 2·12 (1·20–3·76) ..
6 3·10 (2·00–4·79) 2·21 (1·07–4·54) 3·35 (1·72–6·51) ..
7 2·60 (1·35–5·04) 2·09 (0·80–5·48) 3·25 (1·29–8·21) ..
Per 1 SD 1·31 (1·20–1·43) 1·22 (1·08–1·38) 1·43 (1·23–1·67) ..
Sum of skinfolds >90th percentile
1 (reference) 1·00 1·00 1·00 0·98
2 1·11 (0·88–1·40) 1·04 (0·74–1·46) 1·29 (0·92–1·82) ..
3 1·40 (1·14–1·72) 1·35 (0·96–1·88) 1·56 (1·15–2·13) ..
4 1·61 (1·24–2·09) 1·69 (1·09–2·62) 1·70 (1·18–2·45) ..
5 2·02 (1·54–2·64) 2·05 (1·26–3·36) 2·15 (1·49–3·10) ..
6 3·23 (2·29–4·56) 3·20 (1·52–6·74) 3·18 (2·01–5·02) ..
7 2·73 (1·53–4·87) 2·71 (0·97–7·58) 3·06 (1·44–6·51) ..
Per 1 SD 1·35 (1·25–1·45) 1·35 (1·18–1·54) 1·35 (1·23–1·49) ..
Caesarean delivery
1 (reference) 1·00 1·00 1·00 0·47
2 0·98 (0·84–1·13) 1·03 (0·83–1·27) 0·99 (0·79–1·24) ..
3 1·11 (0·96–1·28) 1·06 (0·86–1·32) 1·20 (0·97–1·49) ..
4 1·17 (0·97–1·41) 1·11 (0·81–1·51) 1·33 (1·03–1·73) ..
5 1·20 (0·98–1·48) 1·18 (0·83–1·69) 1·18 (0·88–1·56) ..
6 1·14 (0·84–1·55) 1·42 (0·83–2·45) 1·02 (0·67–1·56) ..
7 2·14 (1·34–3·41) 1·25 (0·57–2·77) 2.88 (1·58–5·25) ..
Per 1 SD 1·09 (1·03–1·15) 1·06 (0·97–1·16) 1·11 (1·02–1·20) ..
Outcome by 2 h post-load glucose category* and per 1 SD
Birthweight >90th percentile
1 (reference) 1·00 1·00 1·00 0·60
2 0·95 (0·74–1·23) 1·00 (0·73–1·37) 0·96 (0·56–1·66) ..
3 1·08 (0·83–1·39) 0·98 (0·71–1·36) 1·04 (0·61–1·76) ..
4 1·29 (0·92–1·80) 1·20 (0·78–1·84) 1·39 (0·72–2·66) ..
5 1·58 (1·14–2·19) 1·18 (0·76–1·82) 2·12 (1·15–3·93) ..
6 1·71 (1·04–2·81) 1·74 (0·90–3·36) 1·66 (0·69–3·98) ..
7 1·29 (0·65–2·60) 1·27 (0·50–3·26) 1·64 (0·54–5·05) ..
Per 1 SD 1·17 (1·07–1·29) 1·10 (0·98–1·24) 1·28 (1·06–1·55) ..
(Table 2 continues on next page)
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Table 3 shows the thresholds of fasting and 2 h post-
load glucose that would result in an OR of 1·75 for 
birthweight greater than the 90th percentile, and sum of 
skinfolds greater than the 90th percentile in each group. 
Fasting and post-load glucose thresholds based on the 
average of birthweight and skinfolds greater than the 
90th percentile for all women irrespective of ethnic 
origin were 5·3 mmol/L and 7·5 mmol/L, respectively. 
Fasting glucose thresholds based on birthweight or the 
average of birthweight and skinfolds greater than the 
90th percentile were higher for white British than south 
Asian women (table 3); with skinfolds greater than the 
90th percentile alone as the outcome, the fasting glucose 
threshold was the same in both ethnic groups. There was 
no 2 h post-load threshold that reached an OR of 1·75 for 
birthweight greater than the 90th percentile in either 
ethnic group. A threshold for sum of skinfolds greater 
than the 90th percentile was only found in south Asian 
women (table 3).
Table 4 shows gestational diabetes prevalence by past 
and present diagnostic criteria, and the criteria derived 
from our data. For our study criteria, we show prevalences 
with the same thresholds in both ethnic groups (the 
thresholds derived for all women) and also ethnic-speciﬁ c 
thresholds. Prevalence of gestational diabetes was about 
twice as high in south Asian women using any criteria 
(range 4·1–17·4%) than in white British women 
(1·2–8·7%) for all (non-ethnic speciﬁ c) criteria. 
Prevalence was greater in both ethnic groups with the 
recently derived IADPSG, UK NICE, and our criteria 
compared with the 1999 WHO criteria. Of the three 
recent criteria, the UK NICE criteria resulted in the 
lowest prevalences in white British women and our 
criteria the highest. In south Asian women, the UK NICE 
criteria resulted in the lowest prevalence. If we applied 
criteria derived in our study for all women (ie, not taking 
account of ethnic origin) to the south Asian women, the 
prevalence of gestational diabetes was the same using 
either IADPSG/WHO or our criteria. However, when we 
applied our ethnic-speciﬁ c criteria, prevalence in south 
Asian women was nearly three times that in white British 
women (table 4).
The amount of missing data ranged from 0 to 32% for 
the diﬀ erent variables (appendix) and 5056 of the 9509 
(53%) had complete data on all variables for the main 
analyses. Distributions of any variable with missing data 
were the same in the imputation datasets and for 
observed complete case data (appendix). Regression 
analyses using only participants with complete data gave 
similar results to those undertaken on the multiple 
imputed datasets presented here (appendix). There was 
no strong evidence for a quadratic curvilinear association 
between fasting or post-load glucose and any of the 
primary or secondary outcomes (appendix). Results of 
analyses restricted to Pakistani women did not diﬀ er 
from those presented for all south Asian women 
(appendix).
Discussion
We recorded graded monotonic associations of fasting 
and 2 h post-load glucose with LGA and high adiposity 
(as assessed by skinfold thickness) across most of the 
glucose distribution in both south Asian and white 
British women. The associations of glucose with LGA 
appeared stronger in south Asian than white British 
women, but there was no statistical evidence of an 
interaction with ethnic origin. Applying the same method 
as the IADPSG to our data, we estimated fasting and 
post-load glucose thresholds for diagnosing gestational 
diabetes that are lower in south Asian compared with 
white British women. For white British women, our 
criteria included a fasting glucose threshold that was 
slightly higher, and a 2 h post-load glucose threshold that 
was markedly lower, than those recommended by the 
IADPSG and WHO. Our results support a lower 
threshold for both fasting and post-load glucose for 
diagnosing gestational diabetes than is currently 
recommended by the UK NICE in both white British and 
south Asian women. The UK NICE supports higher 
fasting glucose thresholds to those proposed by the 
IADPSG and WHO in white British and south Asian 
women, but lower 2 h post-load glucose thresholds. 
Using existing criteria, the prevalence of gestational 
All women (N=9509) 
OR (95% CI)
White British 
(N=3888) 
OR (95% CI)
South Asian 
(N=4821) 
OR (95% CI)*
pinteraction*
(Continued from previous page)
Sum of skinfolds >90th percentile
1 (reference) 1·00 1·00 1·00 0·23
2 1·02 (0·81–1·29) 1·24 (0·88–1·73) 0·96 (0·68–1·35) ..
3 1·32 (1·05–1·65) 1·13 (0·78–1·63) 1·51 (1·10–2·07) ..
4 1·84 (1·40–2·41) 1·76 (1·12–2·76) 1·94 (1·33–2·83) ..
5 1·94 (1·47–2·55) 1·79 (1·13–2·82) 2·22 (1·52–3·25) ..
6 2·29 (1·54–3·39) 2·63 (1·35–5·14) 2·13 (1·25–3·64) ..
7 2·53 (1·53–4·17) 1·80 (0·68–4·77) 3·13 (1·71–5·74) ..
Per 1 SD 1·31 (1·21–1·42) 1·26 (1·11–1·42) 1·38 (1·23–1·54) ..
Caesarean delivery
1 (reference) 1·00 1·00 1·00 0·54
2 0·95 (0·82–1·10) 0·89 (0·72–1·11) 1·06 (0·84–1·32) ..
3 1·07 (0·92–1·24) 1·09 (0·87–1·37) 1·01 (0·80–1·27) ..
4 1·11 (0·91–1·36) 0·96 (0·70–1·32) 1·19 (0·89–1·60) ..
5 1·00 (0·81–1·23) 1·03 (0·76–1·42) 0·97 (0·71–1·33) ..
6 1·31 (0·96–1·79) 1·12 (0·68–1·85) 1·35 (0·88–2·07) ..
7 1·15 (0·76–1·74) 0·86 (0·43–1·72) 1·29 (0·72–2·29) ..
Per 1 SD 1·05 (0·99–1·11) 1·02 (0·94–1·10) 1·05 (0·96–1·14) ..
 *Testing the null hypothesis that the associations of glucose categories with outcome do not diﬀ er between white 
British and south Asian women. †Glucose categories are deﬁ ned as follows: fasting plasma glucose level 
category 1: <4·3 mmol/L; category 2: 4·3–4·4 mmol/L; category 3: 4·5–4·7 mmol/L; category 4: 4·8–4·9 mmol/L; 
category 5: 5·0–5·2 mmol/L; category 6: 5·3–5·6 mmol/L; category 7: 5·7–6·0 mmol/L. Post-load plasma glucose level 
category 1: <4·7 mmol/L; category 2: 4·7–5·4 mmol/L; category 3: 5·5–6·2 mmol/L; category 4: 6·3–6·6 mmol/L; 
category 5: 6·7–7·2 mmol/L; category 6: 7·3–7·5 mmol/L; category 7: 7·6–7·7 mmol/L. 
Table 2: Confounder-adjusted association of gestational fasting and 2 h post-load glucose with primary 
outcomes
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diabetes in our cohort was about twice as high in south 
Asian than in white British women; when we applied the 
ethnic-speciﬁ c criteria derived from our data, the 
prevalence was three times higher in south Asian 
women, and identiﬁ ed about 25% of south Asian women 
as having gestational diabetes.
Overall patterns of associations in our study, for both 
primary and secondary outcomes, were similar to those 
seen in the HAPO study, especially for fasting glucose.4 
Because of diﬀ erences between ours and the HAPO 
study in the post-load glucose threshold used to exclude 
women from the study cohort, our highest 2 h post-load 
category (category 7) was similar to category 4 in the 
HAPO study. As a result, for some outcomes, the linear 
relationship seems to ﬂ atten at the upper end of the 2 h 
post-load glucose categories.
Compared with the IADPSG, who used data from the 
HAPO study, we could not identify a 2 h post-load 
threshold: there was no threshold that reached an OR of 
1·75 for birthweight greater than the 90th percentile, and 
only south Asian women reached a threshold for this OR 
for sum of skinfolds greater than the 90th percentile. The 
IADPSG consensus panel chose 1·75 to represent the 
lowest level of clinically important risk; a lower OR was 
not considered clinically important. Gestational diabetes 
was diagnosed in our study using a lower 2 h post-load 
glucose threshold than in the HAPO study; both studies 
excluded women with gestational diabetes as it would be 
unethical not to treat them. If we had applied the same 
high 2 h post-load glucose threshold as in HAPO to 
diagnose gestational diabetes and to exclude women 
from the main analysis, we would have been more likely 
to identify an OR of 1·75, because women with higher 
glucose concentrations and greater associated risk of the 
primary outcomes would have been included in our 
analyses. The 2 h post-load glucose used to exclude 
women with gestational diabetes in HAPO was much 
higher than that recommended by WHO, and also by 
other criteria recommended at the time that the HAPO 
study began, including the Australasian Diabetes in 
Pregnancy Society criteria. Thus, the 2 h post-load 
glucose threshold used to deﬁ ne gestational diabetes in 
the IADPSG and WHO criteria is higher than that 
suggested by our study (table 1). Because the diagnostic 
criteria for gestational diabetes in our study meant that 
we excluded women from the main analyses with a much 
lower post-load glucose threshold than was the case in 
the HAPO study, we had diﬃ  culty identifying a glucose 
threshold that reached an OR of 1·75 for sum of skinfolds 
greater than the 90th percentile in white British women. 
Therefore, our gestational diabetes diagnostic criteria for 
this group are mainly driven by results of the associations 
with LGA.
Consistent with other studies,25–28 we have shown that 
using any criteria the prevalence of gestational diabetes 
is greater in south Asian compared with white British 
women. When we used the same criteria for both ethnic 
groups, the criteria derived from our study resulted in a 
higher prevalence of gestational diabetes than the UK 
NICE criteria for both white British and south Asian 
women, but broadly similar prevalences for both groups 
to those found with the IADPSG/WHO criteria. When 
we used ethnic-group-speciﬁ c criteria, for white British 
women prevalences remained higher than UK NICE, but 
similar to IADPSG/WHO criteria, whilst those for south 
Asians became higher for both of these other two criteria.
Our study cohort is large and well characterised. The 
broad consistency of our ﬁ ndings with the results of the 
HAPO study, and the fact that our results were 
Figure 2: Frequency of primary outcomes across glucose categories by ethnic origin (white British [N=3888] 
and south Asian [N=4821]) 
Glucose categories are deﬁ ned as follows: fasting plasma glucose level category 1: <4·3 mmol/L; category 
2: 4·3–4·4 mmol/L; category 3: 4·5–4·7 mmol/L; category 4: 4·8–4·9 mmol/L; category 5: 5·0–5·2 mmol/L; category 
6: 5·3–5·6 mmol/L; category 7: 5·7–6·0 mmol/L. Post-load plasma glucose level category 1: <4·7 mmol/L; category 
2: 4·7–5·4 mmol/L; category 3: 5·5–6·2 mmol/L; category 4: 6·3–6·6 mmol/L; category 5: 6·7–7·2 mmol/L; category 
6: 7·3–7·5 mmol/L; category 7: 7·6–7·7 mmol/L.
0
5
10
15
20
Fr
eq
ue
nc
y 
(%
)
0
5
10
15
20
Fr
eq
ue
nc
y 
(%
)
25
30
0
0 1 2 3 4
Glucose category
5 6 7
1448 (38·2)
1275 (26·5)
1133 (29·1)
1024 (21·2)
930 (23·9)
1026 (21·3)
1081 (27·8)
1412 (29·3)
877 (22·6)
1245 (25·8)
914 (23·5)
 1264 (26·2)
308 (7·9)
567 (11·8)
318 (8·2)
446 (9·3)
199 (5·1)
456 (9·5)
299 (7·7)
435 (9·0)
61 (1·6)
191 (4·0)
93 (2·4)
153 (3·2)
29 (0·8)
61 (1·3)
50 (1·3)
87 (1·8)
10
20
30
Fr
eq
ue
nc
y 
(%
)
40
50
Fasting (white British)
Post-load (white British)
Fasting (south Asian)
Post-load (south Asian)
A Birthweight >90th percentile
B Sum of skinfolds >90th percentile
C Caesarean section
Fasting glucose 
values
White British
South Asian
Post-load glucose 
values
White British
South Asian
Articles
802 www.thelancet.com/diabetes-endocrinology   Vol 3   October 2015
unchanged when we limited the analyses in south Asians 
to those of Pakistani origin, suggest the results might be 
generalisable to all white Europeans and south Asians. 
Some participants had missing data for some variables, 
but the distribution of recorded variables and those from 
the pooled multiple imputed datasets were similar, as 
were the association results. We did not collect data for 
1 h post-load glucose concentrations, which were 
measured in the HAPO study, and a 1 h post-load glucose 
threshold is included in IADPSG/WHO criteria for 
gestational diabetes. Although the HAPO study found 
linear associations of 1 h glucose with adverse perinatal 
outcomes, none of the randomised trials that have shown 
the eﬀ ect of treatments on adverse perinatal outcomes 
have used this to deﬁ ne gestational diabetes. 
Furthermore, it is unclear how many additional women 
this additional glucose measurement identiﬁ es in 
diﬀ erent populations. Thus, the beneﬁ t of this additional 
measurement remains somewhat unclear. We do not 
have data for cord-blood C-peptide concentrations or 
neonatal hypoglycaemia. High cord-blood C-peptide 
concentrations were one of the criteria used by the 
IADPSG in the development of their diagnostic criteria; 
this additional information might have aﬀ ected our 
results. However, the similar prevalences of gestational 
diabetes in white British women using the IADPSG/
WHO criteria or our study criteria suggest including 
these data would not have markedly changed our results.
Concerns have been raised about the increased 
prevalence of gestational diabetes and hence the cost to 
health services if the IADPSG criteria are used worldwide 
in place of the previously widely used 1999 WHO 
criteria.9,29,30 Until the late 1990s, the main aim of 
diagnosing gestational diabetes was to identify women at 
risk of subsequent type 2 diabetes.31 By contrast, the 
outcomes used to develop the IADPSG criteria, which we 
also used, were chosen to identify oﬀ spring at risk of 
future high adiposity and cardiometabolic risk.31 
Although there is evidence that gestational diabetes 
causes greater adiposity in oﬀ spring in later life,31,32 there 
is still debate about the validity of that evidence.33 Thus, 
the extent to which the IADPSG or our criteria will 
accurately predict future adverse oﬀ spring health 
remains to be established. Conversely, in view of the 
graded association of maternal glucose concentrations 
with adverse perinatal outcomes, lowering the thresholds 
used to diagnose gestational diabetes would identify 
more pregnancies at risk of these outcomes. Because 
eﬀ ective, safe, and cheap treatments are available for 
gestational diabetes (eg, lifestyle advice, metformin, and 
insulin) that reduce glucose across its distribution and 
help prevent adverse perinatal outcomes,34,35 applying the 
IADPSG/WHO 2013 or our criteria in place of the WHO 
1999 criteria, and also in place of the recently suggested 
UK NICE criteria, might improve perinatal outcomes. 
Criteria (all deﬁ ne gestational 
diabetes as glucose 
concentrations at or above one or 
more of the following)
Prevalence in our study 
population (%, 95% CI)
Fasting 
glucose 
(mmol/L)
1 h 
post-load 
glucose 
(mmol/L)
2 h 
post-load 
glucose 
(mmol/L)
White British South Asian
Older criteria used
Exclusion in HAPO* 5·8 .. 11·1 1% (0·9–1·5) 4% (3·6–4·7)
WHO (previous)† 7·0 .. 7·8 5% (4·1–5·4) 10% (9·6–11·2)
WHO (previous, modiﬁ ed)‡ 6·1 .. 7·8 5% (4·3–5·6) 11% (10·0–11·7)
Recently proposed criteria
UK NICE§ 5·6 .. 7·8 6% (5·2–6·6) 13% (11·7–13·4)
IADPSG/WHO (current)¶ 5·1 10·8 8·5 8% (6·8–8·5) 17% (16·3–18·3)
Our study
Same criteria for all women|| 5·3 .. 7·5 9% (7·9–9·6) 17% (16·4–18·4)
For white British 5·4 .. 7·5 8% (7·5–9·2) ..
For south Asian 5·2 .. 7·2 .. 24% (23·1–25·3)
HAPO=Hyperglycaemia and Adverse Pregnancy Outcomes study. NICE=National Institute for health and Care 
Excellence. IADPSG=International Association of Diabetes and Pregnancy Study Groups.*Used in the HAPO study to 
exclude women with gestational diabetes. †Used by WHO up to 2013.17 ‡Criteria used for all pregnant women in 
Bradford (and in other populations) at the time that women were recruited for the Born in Bradford study and used 
here to exclude those with gestational diabetes. §Criteria in current UK guidelines.36 ¶Criteria were developed using 
HAPO data and were adopted by WHO in 2013.2,3 ||Criteria developed in this study.
Table 4: Prevalence of gestational diabetes in south Asian and white British women using diﬀ erent criteria
All women (N=10 356) White British women (N=4105) South Asian women (N=5445)
Fasting 
glucose 
threshold 
(mmol/L)
2 h post-load 
glucose 
threshold 
(mmol/L)
Fasting glucose 
threshold 
(mmol/L)
2 h post-load 
glucose 
threshold 
(mmol/L)
Fasting 
glucose 
threshold 
(mmol/L)
2 h post-load 
glucose 
threshold 
(mmol/L)
Birthweight >90th percentile 5·3 NP 5·6 NP 5·1 NP
Sum skinfolds >90th percentile 5·2 7·5 5·2 NP 5·2 7·2
Average glucose concentration for 
both birthweight and sum of skinfolds 
>90th percentile
5·3 7·5 5·4 NP 5·2 7·2
NP=not possible to work out a threshold because within our study none of the women reached a threshold that gave an odds ratio of 1·75 or greater (the International 
Association of Diabetes and Pregnancy Study Groups consensus minimal odds ratio deemed to be of clinical importance). 
Table 3: Thresholds of fasting and post-load glucose concentrations that would identify an odds ratio of roughly 1·75 for birthweight >90th percentile 
and sum of skinfolds >90th percentile
Articles
www.thelancet.com/diabetes-endocrinology   Vol 3   October 2015 803
Because the UK NICE 2015 criteria recommend higher 
thresholds of fasting and post-load glucose than the 
IADPSG/WHO or our newly deﬁ ned criteria, their use 
will identify fewer women who are at increased risk of 
adverse outcomes.36
To conclude, our data support the use of lower fasting 
and post-load glucose thresholds in south Asian than in 
white British women. They also suggest that compared 
with our criteria or those of the IADPSG/WHO, the 
criteria recommended by UK NICE might underestimate 
the prevalence of gestational diabetes, especially in south 
Asian women. The use of our ethnic-speciﬁ c thresholds 
for diagnosing gestational diabetes in south Asian women, 
and of either our, or the IASPSG/WHO, criteria for white 
European women might reduce the occurrence of adverse 
perinatal outcomes, in particular LGA, as more at-risk 
women would be treated. However, the cost-eﬀ ectiveness 
of applying our criteria, and the eﬀ ect of applying any of 
the recently proposed criteria on later-life adiposity and 
associated cardiometabolic health in oﬀ spring are 
unknown and require further investigation.
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